scholarly journals Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017

2018 ◽  
Vol 23 (46) ◽  
Author(s):  
Enrico Ricchizzi ◽  
Katrien Latour ◽  
Tommi Kärki ◽  
Rossella Buttazzi ◽  
Béatrice Jans ◽  
...  
Keyword(s):  
Long Term Care ◽  
Antimicrobial Use ◽  
Healthcare Associated Infections ◽  
Term Care ◽  
The Third ◽  
Care Facilities ◽  
Tract Infections ◽  
Healthcare Associated ◽  
The Eu

Antimicrobials are commonly prescribed and contribute to the development of antimicrobial resistance in long-term care facilities (LTCFs). In 2010, the European Centre for Disease Prevention and Control initiated point prevalence surveys (PPS) of healthcare-associated infections and antimicrobial use in European LTCFs, performed by external contractors as the Healthcare-Associated infections in Long-Term care facilities (HALT) projects. Here, we investigated prevalence and characteristics of antimicrobial use and antimicrobial stewardship indicators in European LTCFs in 2016–17. Twenty-four European Union/European Economic Area (EU/EEA) countries, the former Yugoslav Republic of Macedonia and Serbia participated in the third PPS in European LTCFs. Overall, 4.9% (95% confidence interval: 4.8–5.1) of LTCF residents in the EU/EEA participating countries received at least one antimicrobial. The most commonly reported Anatomical Therapeutic Chemical (ATC) groups were beta-lactam antibacterials/penicillins (J01C), other antibacterials (J01X) (e.g. glycopeptide antibacterials, polymyxins), quinolones (J01M), sulfonamides and trimethoprim (J01E), and other beta-lactams (J01D). Urinary tract infections and respiratory tract infections were the main indications for antimicrobial prescription. This PPS provides updated and detailed information on antimicrobial use in LTCFs across the EU/EEA that can be used to identify targets for future interventions, follow-up of these interventions and promote prudent use of antimicrobials in European LTCFs.

scholarly journals Prospective Surveillance of Healthcare-Associated Infections in Residents in Four Long-Term Care Facilities in Graz, Austria

Antibiotics ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 544
Author(s):  
Elisabeth König ◽  
Mara Medwed ◽  
Christian Pux ◽  
Michael Uhlmann ◽  
Walter Schippinger ◽  
...  
Keyword(s):  
Incidence Rate ◽  
Long Term Care ◽  
Health Centre ◽  
Healthcare Associated Infections ◽  
Prospective Surveillance ◽  
Term Care ◽  
Care Facilities ◽  
Tract Infections ◽  
Healthcare Associated

Healthcare-associated infections (HCAI) are a common cause for residents’ mortality and morbidity associated with a significant socio-economic burden. Data on HCAIs in Austrian long-term care facilities are scare. Therefore, we evaluated the incidence rate of HCAIs per 1000 resident days in four LTC facilities in Graz, Austria, characterized the spectrum of HCAIs and the use of antimicrobial substances. We conducted a prospective surveillance study from 1 January to 31 December 2018 in four LTCFs of the Geriatric Health Centre of the City of Graz (total of 388 beds). Nursing staff collected data on HCAIs once a week using an electronic reporting system. During the 12-month surveillance period, 252 infections of 165 residents were recorded. The overall incidence rate of HCAIs was 2.1 per 1000 resident days. Urinary tract infections were the most commonly recorded HCAIs (49%, 124/252, 1.03 per 1000 resident days), followed by skin and soft tissue infections and respiratory tract infections. Beta-lactams (ATC class J01C) were prescribed most frequently (63/212), followed by fluoroquinolones (J01M; 54/212). In conclusion, the overall incidence rate for HCAIs was relatively low at 2.1 per 1000 resident days. Our real-life data can serve as a basis for future antimicrobial stewardship and infection prevention interventions.

PS-074 Healthcare associated infections in Long-Term Care Facilities in Asti (Italy)

2014 ◽  
Vol 21 (Suppl 1) ◽  
pp. A173.3-A174
Author(s):  
R Bona ◽  
D Piccioni ◽  
R Broda ◽  
A Mesto ◽  
P Mero ◽  
...  
Keyword(s):  
Long Term Care ◽  
Healthcare Associated Infections ◽  
Term Care ◽  
Care Facilities ◽  
Healthcare Associated

scholarly journals Epidemiology of Healthcare-Associated Infections in Pediatric Long-Term Care Facilities

2016 ◽  
Vol 3 (suppl_1) ◽  
Author(s):  
Philip Maykowski ◽  
Meghan Murray ◽  
Bevin Cohen ◽  
Natalie Neu ◽  
Gordon Hutcheon ◽  
...  
Keyword(s):  
Long Term Care ◽  
Healthcare Associated Infections ◽  
Term Care ◽  
Care Facilities ◽  
Healthcare Associated

scholarly journals Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017

2018 ◽  
Vol 23 (46) ◽  
Author(s):  
Carl Suetens ◽  
Katrien Latour ◽  
Tommi Kärki ◽  
Enrico Ricchizzi ◽  
Pete Kinross ◽  
...  
Keyword(s):  
Antimicrobial Resistance ◽  
Acute Care ◽  
Long Term Care ◽  
Acute Care Hospitals ◽  
Point Prevalence ◽  
Healthcare Associated Infections ◽  
Term Care ◽  
Care Facilities ◽  
Healthcare Associated

Point prevalence surveys of healthcare-associated infections (HAI) and antimicrobial use in the European Union and European Economic Area (EU/EEA) from 2016 to 2017 included 310,755 patients from 1,209 acute care hospitals (ACH) in 28 countries and 117,138 residents from 2,221 long-term care facilities (LTCF) in 23 countries. After national validation, we estimated that 6.5% (cumulative 95% confidence interval (cCI): 5.4–7.8%) patients in ACH and 3.9% (95% cCI: 2.4–6.0%) residents in LTCF had at least one HAI (country-weighted prevalence). On any given day, 98,166 patients (95% cCI: 81,022–117,484) in ACH and 129,940 (95% cCI: 79,570–197,625) residents in LTCF had an HAI. HAI episodes per year were estimated at 8.9 million (95% cCI: 4.6–15.6 million), including 4.5 million (95% cCI: 2.6–7.6 million) in ACH and 4.4 million (95% cCI: 2.0–8.0 million) in LTCF; 3.8 million (95% cCI: 3.1–4.5 million) patients acquired an HAI each year in ACH. Antimicrobial resistance (AMR) to selected AMR markers was 31.6% in ACH and 28.0% in LTCF. Our study confirmed a high annual number of HAI in healthcare facilities in the EU/EEA and indicated that AMR in HAI in LTCF may have reached the same level as in ACH.

Sign in / Sign up

Export Citation Format

Share Document